employer coverage glp-1 news october 2025 Massachusetts cuts for 460K public workers and retirees, jeopardizing obesity care and risking higher long-term health costs. Learn more: Health Benefits In 2025: Family
Description
Sherry Shen, MD, shares retrospective data on how GLP-1s influence overall survival and safety outcomes among patients with breast cancer.
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed the therapeutic landscape of type 2 diabetes (T2D) and obesity by offering substantial weight loss and cardiometabolic protection
If you have chronic kidney disease, or you love someone who does, you have probably heard about SGLT2 inhibitors and GLP-1 receptor agonists
doi: 10.3390/nu15041013
Lemme GLP-1 Daily faces lawsuits alleging misleading claims about boosting GLP-1 levels and weight loss
